Two Sigma Investments
BBOT

Two Sigma Investments’s BridgeBio Oncology BBOT Stock Holding History

Two Sigma Investments’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-189,285
Closed -$2.14M – 3610
2025
Q1 		$2.14M Hold
189,285
– – ﹤0.01% 1696
2024
Q4 		$1.99M Hold
189,285
– – ﹤0.01% 1719
2024
Q3 		$1.98M Hold
189,285
– – ﹤0.01% 1690
2024
Q2 		$1.93M Hold
189,285
– – ﹤0.01% 1572
2024
Q1 		$1.97M Buy
+189,285
New +$1.96M ﹤0.01% 1491

Other funds holding BBOT

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HCI
Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return

Two Sigma Investments's BBOT Position: Q2 2025 in Review

Two Sigma Investments sold out of BridgeBio Oncology (BBOT) in Q2 2025, closing a stake of 189,285 shares — an estimated $2.14M sold.

Two Sigma Investments first reported a position in BBOT in Q1 2024 and held it in 5 quarters. The position peaked at $2.14M in Q1 2025. 34 funds tracked by Wall St. Rank hold BBOT as of Q2 2025.

  • Two Sigma Investments reported no remaining BridgeBio Oncology position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Investments sold 189,285 BridgeBio Oncology shares in Q2 2025, an estimated $2.14M.
  • Two Sigma Investments first reported a position in BridgeBio Oncology in Q1 2024 and held it in 5 quarters.
  • Two Sigma Investments's BridgeBio Oncology position peaked at $2.14M in Q1 2025.
  • 34 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.